Insider: Matsuda Masaru See Remarks - Arcutis Biotherapeutics, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 136,932 | 0 | 136,932 |
| Value | $3,300,061.20 | $0.00 | $3,300,061.20 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 03/02/2026 | DDS | 1,987 | Direct | COM | $25.70 | $51,065.90 | 136,932 |
| 03/02/2026 | DDS | 6,553 | Direct | COM | $25.16 | $164,876.10 | 137,125 |
| 03/02/2026 | DDS | 193 | Direct | COM | $25.91 | $5,001.38 | 136,932 |
| 02/27/2026 | DDS | 3,325 | Direct | COM | $27.95 | $92,933.75 | 143,678 |
| 02/02/2026 | DDS | 8,562 | Direct | COM | $24.97 | $213,793.14 | 134,096 |
| 02/02/2026 | DDS | 7,983 | Direct | COM | $25.50 | $203,553.73 | 142,658 |
| 02/02/2026 | DDS | 19,379 | Direct | COM | $25.24 | $489,125.96 | 114,717 |
| 02/02/2026 | DDS | 4,714 | Direct | COM | $25.63 | $120,819.82 | 110,003 |
| 12/01/2025 | DDS | 1,657 | Direct | COM | $30.23 | $50,091.11 | 150,641 |
| 11/19/2025 | DDS | 989 | Direct | COM | $27.95 | $27,646.60 | 153,037 |
| 11/19/2025 | DDS | 1,561 | Direct | COM | $28.50 | $44,488.50 | 151,476 |
| 11/03/2025 | DDS | 7,165 | Direct | COM | $24.71 | $177,063.63 | 154,069 |
| 11/03/2025 | DDS | 43 | Direct | COM | $25.40 | $1,092.14 | 154,026 |
| 09/04/2025 | DDS | 36,130 | Direct | COM | $16.16 | $583,716.28 | 161,234 |
| 08/04/2025 | DDS | 6,330 | Direct | COM | $14.33 | $90,687.38 | 197,364 |
| 05/28/2025 | DDS | 1,800 | Direct | COM | $13.78 | $24,806.52 | 202,599 |
| 05/02/2025 | DDS | 5,030 | Direct | COM | $15.20 | $76,453.49 | 204,399 |
| 03/03/2025 | DDS | 3,263 | Direct | COM | $13.03 | $42,520.48 | 209,429 |
| 02/03/2025 | DDS | 8,338 | Direct | COM | $12.70 | $105,892.60 | 178,692 |
| 11/30/2024 | AAP | 1,657 | Direct | COM | $7.11 | $11,774.64 | 187,030 |
| 11/19/2024 | DDS | 1,775 | Direct | COM | $9.68 | $17,190.34 | 181,373 |
| 11/04/2024 | DDS | 5,015 | Direct | COM | $8.68 | $43,551.26 | 178,273 |
| 08/02/2024 | DDS | 5,220 | Direct | COM | $9.02 | $47,064.04 | 183,288 |
| 05/31/2024 | AAP | 4,000 | Direct | COM | $1.69 | $6,768.00 | 185,373 |
| 05/28/2024 | DDS | 1,775 | Direct | COM | $9.01 | $15,988.14 | 188,508 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research